Changeflow GovPing Telecom & Technology Recursion Pharmaceuticals Biological Vector Spa...
Routine Notice Added Final

Recursion Pharmaceuticals Biological Vector Space Patent, EP4294937A1, Apr 15, 2026

Favicon for changeflow.com EPO Patent Bulletin - AI & Computing (G06N)
Published
Detected
Email

Summary

The European Patent Office published European Patent Application EP4294937A1 to Recursion Pharmaceuticals, Inc. on April 15, 2026, granting enforceable intellectual property rights to the applicant and four named inventors (EARNSHAW, JENSEN, KHALIULLIN, LAZAR) in designated states covering EU member states and additional EPC contracting states.

Published by EPO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

About this source

GovPing monitors EPO Patent Bulletin - AI & Computing (G06N) for new telecom & technology regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 86 changes logged to date.

What changed

The European Patent Office published European Patent EP4294937A1, a new patent application describing methods for determining the goodness of biological vector space representations, utilizing neural network architectures. The patent spans multiple IPC classifications including G06N 3/0464, G06N 3/045, and G06N 3/08.

Recursion Pharmaceuticals, Inc. and its four named inventors now hold enforceable intellectual property rights in designated contracting states covering EU member states and additional EPC countries. Competitors in computational biology and AI-driven drug discovery should consider potential licensing implications or design-around requirements for similar vector space evaluation methods.

Archived snapshot

Apr 26, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← EPO Patent Bulletin

DETERMINING THE GOODNESS OF A BIOLOGICAL VECTOR SPACE

Publication EP4294937A1 Kind: A1 Apr 15, 2026

Applicants

Recursion Pharmaceuticals, Inc.

Inventors

EARNSHAW, Berton, JENSEN, James, KHALIULLIN, Renat, LAZAR, Nathan

IPC Classifications

G06V 20/69 20220101AFI20260309BHEP G06V 10/82 20220101ALI20260309BHEP G06N 3/0464 20230101ALI20260309BHEP G06V 10/40 20220101ALI20260309BHEP G06V 10/74 20220101ALI20260309BHEP G06V 10/98 20220101ALI20260309BHEP G06V 10/771 20220101ALI20260309BHEP G06V 10/778 20220101ALI20260309BHEP G06N 3/045 20230101ALI20260309BHEP G06N 3/08 20230101ALN20260309BHEP

Designated States

AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR

View original document →

Get daily alerts for EPO Patent Bulletin - AI & Computing (G06N)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from EPO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
EPO
Published
April 15th, 2026
Instrument
Notice
Branch
International
Legal weight
Binding
Stage
Final
Change scope
Minor
Document ID
EP4294937A1

Who this affects

Applies to
Pharmaceutical companies
Industry sector
3254.1 Biotechnology
Activity scope
Patent grant Biotechnology research
Geographic scope
European Union EU

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Artificial Intelligence

Get alerts for this source

We'll email you when EPO Patent Bulletin - AI & Computing (G06N) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!